Healthcare costs of Type 2 diabetes in Germany von Jacobs, E., Hoyer, A., Brinks, R., Icks, A., Kuß, O., Rathmann, W.

Volltext

Projected number of people with diagnosed Type 2 diabetes in Germany in 2040 von Tönnies, T., Röckl, S., Hoyer, A., Heidemann, C., Baumert, J., Du, Y., Scheidt‐Nave, C., Brinks, R.

Volltext

Excess mortality for people diagnosed with type 2 diabetes in 2012 – Estimates based on claims data from 70 million Germans von Tönnies, T., Hoyer, A., Brinks, R.

Volltext

High socioeconomic impact on prescription behavior despite unrestricted access to disease-modifying therapies in people with multiple sclerosis von Samadzadeh, S, Havla, J, Lepka, K, Brinks, R, Meuth, S G, Klotz, L, Albrecht, P

Volltext

Age at diagnosis of Type 2 diabetes in Germany: a nationwide analysis based on claims data from 69 million people von Jacobs, E., Rathmann, W., Tönnies, T., Arendt, D., Marchowez, M., Veith, L., Kuss, O., Brinks, R., Hoyer, A.

Volltext

Trends in incidence of diabetes in Jordan between 1994 and 2017 von Tönnies, T., Hoyer, A., Brinks, R.

Volltext

Quality of care predicts outcome in systemic lupus erythematosus: a cross-sectional analysis of a German long-term study (LuLa cohort) von Kernder, A, Richter, J G, Fischer-Betz, R, Winkler-Rohlfing, B, Brinks, R, Schneider, M, Chehab, G

Volltext

Projection of the burden of Type 2 diabetes mellitus in Germany: a demographic modelling approach to estimate the direct medical excess costs from 2010 to 2040 von Waldeyer, R., Brinks, R., Rathmann, W., Giani, G., Icks, A.

Volltext

Medical adherence in patients with systemic lupus erythematosus in Germany: predictors and reasons for non-adherence – a cross-sectional analysis of the LuLa-cohort von Chehab, G, Sauer, G M, Richter, J G, Brinks, R, Willers, R, Fischer-Betz, R, Winkler-Rohlfing, B, Schneider, M

Volltext

Age-specific prevalence of diagnosed systemic lupus erythematosus in Germany 2002 and projection to 2030 von Brinks, R, Fischer-Betz, R, Sander, O, Richter, J G, Chehab, G, Schneider, M

Volltext

Possible trends in incidence of diabetes in Italy von Hoyer, A., Tönnies, T., Brinks, R.

Volltext

Incidence of systemic lupus erythematosus in Colombia: data from the National Health Registry 2012–2016 von Haase, I, Mucke, J, Chehab, G, Fischer-Betz, R, Schneider, M, Brinks, R

Volltext

Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study von Fischer-Betz, R, Specker, C, Brinks, R, Schneider, M

Volltext

Success quotas in exercise questions in the discipline of rheumatology in preparation for the written state examination in German universities from 2012 to 2016 : Evaluation of the... von Sengewein, R, Brinks, R, Pongratz, G

Volltext

Response to Monesi et al. Prevalence, incidence and mortality of diagnosed diabetes: evidence from an Italian population-based study von Brinks, R., Rathmann, W.

Volltext

Determinants of health-related quality of life in systemic lupus erythematosus: a monocentric, retrospective long-term observational study in Germany von Vordenbäumen, S, Brinks, R, Sander, O, Chehab, G, Lozitiello-Kiroudis, G, Acar, H, Richter, J, Fischer-Betz, R, Schneider, M

Volltext

SAT0169 High Risk of Flares During Pregnancy in Women with Rheumatoid Arthritis Who Discontinue Treatment with TNF-Inhibitors at Conception von Fischer-Betz, R., Sander, O., Specker, C., Brinks, R., Schneider, M.

Volltext

Need for improvements in reported cost effectiveness of adalimumab in rheumatoid arthritis von Weber, S., Pongratz, G., Schneider, M., Brinks, R.

Volltext

SAT0285 Vaccinations in SLE: Coverage and Reasons for Non-Vaccination - Results from The Lula-Study von Chehab, G., Richter, J.G., Brinks, R., Fischer-Betz, R., Winkler-Rohlfing, B., Schneider, M.

Volltext

Response to Hex et al. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs... von Waldeyer, R., Brinks, R., Giani, G.

Volltext